Archive
Frequency Exchange Corp. Appoints Gail Edgell To Advisory Board
 | |||||||||
Gail Edgell brings over 25 years of experience in the wellness industry, with leadership roles across corporate wellness, professional supplements, biotechnology startups, and integrative clinical consulting. She has held strategic positions focused on market development, practitioner engagement, and education-based commercialization, contributing to consistent revenue growth across several companies.
Her career includes senior contributions at Designs for Health, where she helped scale practitioner channel sales from $360,000 to $1.5 million in under three years, and at Bio-Botanical Research, where she launched a practitioner partnership model that reached $1 million in annualized revenue within 90 days. Ms. Edgell has also supported business development efforts at Panaceutics Nutrition, a biotech startup, and has advised numerous integrative health clinics on operational growth and patient education strategies
“Gail brings a deep understanding of the wellness practitioner ecosystem and how to build lasting commercial and educational relationships in that space,” said Stephen Davis, CEO of Frequency Exchange Corp. “Her insights will support our efforts to scale NIKKI’s reach into professional, consumer, and community-based health channels.”
Ms. Edgell is also a published author, founder of Inside Out Wellness, and a former nonprofit executive who led wellness-focused programs serving over 300 organizations and communities. She continues to collaborate with leading nutrition companies and healthcare educators to reimagine practitioner support experiences.
Frequency Exchange Corp. (TSXV: FREQ; OTC: FRECF) is the parent company of FREmedica Technologies Inc., a developer and commercializer of frequency-based digital wellness technologies. The Company’s flagship product, NIKKI, delivers programmable frequency wellness programs designed to support cellular communication and overall wellbeing.
Originally developed to support those with Lyme disease, the NIKKI platform has evolved to address broader use cases, including sleep, pain, energy, immune support, and athletic recovery. The Company’s technology is supported by ongoing testing and quality-of-life evaluations.
For more information, please contact:
Frequency Exchange Corp. FREmedica Technologies Inc.
Stephen Davis Nicole Sullivan
CEO & Director President
250-732-7170 Nicole.sullivan@wearenikki.com
Cautionary Note Regarding Forward-Looking Information
Certain information contained herein constitutes “forward-looking information” under Canadian securities legislation. All statements, other than statements of historical fact, included in this news release are forward-looking statements that involve risks and uncertainties. In particular, forward-looking information includes, but is not limited to, statements with respect to the Company’s use of proceeds from the private placement. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “will” or variations of such words and phrases or statements that certain actions, events or results “will” occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on forward-looking statements and forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available under the Company’s profile on SEDAR+ at www.sedarplus.ca.
Neither the Exchange nor its Regulation Services Provider (as that term is defined in policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.